About Emily

Emily practices general corporate and securities law. She advises clients on a range of corporate matters – including formation, financings, mergers & acquisitions, securities offerings, US Securities and Exchange Commission (SEC) reporting obligations, and corporate governance.

View full bio

Experience

Capstan Therapeutics Announces up to $2.1 Billion Acquisition by AbbVie

Capstan Therapeutics Announces up to $2.1 Billion Acquisition by AbbVie

June 30, 2025

Cooley advised Capstan Therapeutics, a clinical-stage biotechnology company with a mission to multiply therapeutic possibilities for patients through targeted in vivo RNA technologies, on its definitive agreement to be acquired by AbbVie.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Ken Rollins
Partner in Charge – San Diego, San Diego
Edmond Lay
Partner, San Diego
Charity Williams
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
W. Chad Shear
Partner, San Diego
Jeffrey J. Tolin
Partner, New York
Stacey A. Bradford
Special Counsel, Washington, DC
Chen Chen
Special Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Rachel Thorn
Of counsel, New York
Alexandria Ashour
Associate, San Diego
Navya Dasari
Associate, New York
Joshua Elefant
Associate, Palo Alto
Tony P. Guan
Associate, Santa Monica
Michelle Hunt
Associate
Emily Mok
Associate, Reston
Jonathan Perez-Reyzin
Associate, San Diego
Breanna Qin
Associate, Palo Alto
David D. Suh
Associate
Christopher Suhler
Associate, Colorado
Novak Topalovic
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Rubin Waranch
Associate, Colorado
Yuhan Wu
Associate, Palo Alto
Joanna Zhang
Associate, San Diego
Jessica Wade
Paralegal Specialist, San Diego

Related Practices & Industries

Mergers and Acquisitions
Life Sciences
Healthcare
Biotechnology
Life Sciences and Healthcare Regulatory
Life Sciences Corporate Partnering and Licensing
Emerging Companies
Tax
CFIUS
Labor and Employment
Cyber/Data/Privacy
Antitrust and Competition
Compensation and Benefits
Capital Markets
Commercial Litigation

Rhino.ai Announces $50 Million Series A

Rhino.ai Announces $50 Million Series A

February 6, 2025

Cooley represented Rhino.ai, an artificial intelligence-powered enterprise platform, in its $50 million Series A preferred stock financing.

Read more

Related contacts

Mike Lincoln
Vice Chair, Reston
Kevin Milgram
Associate, Reston
Sarah Howard
Associate, Washington, DC
Emily Mok
Associate, Reston
Christian Plaza
Partner, Reston
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

Emerging Companies
Artificial Intelligence
Venture Capital

Admissions and credentials

Virginia

District of Columbia

New York